More recently, the same group compared the available response criteria for PCa, both specific (aPCWG3, PPP and RECIP 1.0) and non-specific (RECIST 1.1, aPERCIST), in the response evaluation of patients treated with [177Lu]Lu-PSMA. This evidence concerns the gene FOLH1 and posterior cortical atrophy.